EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantification of atrial cardiomyopathy disease severity by electroanatomic voltage mapping and cardiac magnetic resonance imaging

Iain Sim iD, Jose Alonso Solis Lemus, Christopher O'Shea, Orod Razeghi iD, John Whitaker, Rahul Mukherjee, Daniel O'Hare, Noel Fitzpatrick, James Harrison, Ali Gharaviri, Louisa O'Neill iD, Irum Kotadia und 10 weitere

Journal of Cardiovascular Electrophysiology · 2025-02 · 36 (2) · 467-479

DOI: 10.1111/jce.16462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 30.12.2024. Verfasst von Iain Sim und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Imaging Sciences and Biomedical Engineering, King's College London, London, UK. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiomyopathies, Action Potentials, Heart Atria. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Atrial late gadolinium enhancement (Atrial‐LGE) and electroanatomic voltage mapping (Atrial‐EAVM) quantify the anatomical and functional extent of atrial cardiomyopathy. We aimed to explore the relationships between, and outcomes from, these modalities in patients with atrial fibrillation undergoing ablation.

Methods

Patients undergoing first‐time ablation had disease severities quantified using both Atrial‐LGE and Atrial‐EAVM. Correlations between modalities and their relationships with clinical features and arrhythmia recurrence were assessed.

Results

In 123 atrial fibrillation patients (60 ± 10 years), Atrial‐EAVM was moderately correlated with Atrial‐LGE ( r = .34, p < .001), with a mean fibrosis burden of 47.2% ± 14.91%. Agreement was strongest in the highest tertile of fibrosis burden (mean of differences 16.8% (95% CI = −24.4% to 57.9%, p = .433). Fibrosis burden was greater for Atrial‐LGE than Atrial‐EAVM (50.7% ± 10.7% vs. 13.7% ± 7.13%, p < .005) for patients in the lowest tertile who were younger, had smaller atria and a greater frequency of paroxysmal atrial fibrillation. Both Atrial EAVM and Atrial LGE were associated with recurrence of arrhythmia following ablation (Atrial‐LGE HR = 1.02 (95% CI = 1.01–1.04), p = .047; Atrial‐EAVM HR = 1.02 (95% CI = 1.005–1.03), p = .007). A low fibrosis burden (66%) by Atrial‐LGE identified patients failing to respond to ablation.

Conclusions

We demonstrate for the first time that the level of agreement between Atrial‐EAVM and Atrial‐LGE is dependent on the level of atrial cardiomyopathy disease severity. The functional consequences of atrial cardiomyopathy are most evident in patients with the highest anatomical extent of disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCardiomyopathiesAction PotentialsHeart AtriaElectrophysiologic Techniques, CardiacMagnetic Resonance ImagingHumansMaleMiddle AgedFemaleAgedSeverity of Illness IndexPredictive Value of TestsFibrosisRecurrenceCatheter AblationTreatment OutcomeContrast MediaRetrospective Studies

Stichwörter der Autor:innen

atrial fibrillationbipolar voltagefibrosislate gadolinium enhancement

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Division of Imaging Sciences and Biomedical Engineering, King's College London, London, UK.
  • Department of Cardiovascular Scienes, University of Birmingham, Birmingham, UK.
  • Department of Cardiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK.

ORCID-Profile: Iain Sim, Orod Razeghi, Louisa O'Neill, Mark O'Neill

Förderung

  • Wellcome Trust
  • British Heart Foundation

Zitieren

APA

Sim, I., Lemus, J. A. S., O'Shea, C., Razeghi, O., Whitaker, J., Mukherjee, R., O'Hare, D., Fitzpatrick, N., Harrison, J., Gharaviri, A., O'Neill, L., Kotadia, I., Roney, C. H., Grubb, N., Newby, D. E., Dweck, M. R., Masci, P. G., Wright, M., Chiribiri, A., …, & Williams, S. E. (2025). Quantification of atrial cardiomyopathy disease severity by electroanatomic voltage mapping and cardiac magnetic resonance imaging. Journal of Cardiovascular Electrophysiology, 36(2), 467-479. https://doi.org/10.1111/jce.16462

Vancouver

Sim I, Lemus JAS, O'Shea C, Razeghi O, Whitaker J, Mukherjee R, et al. Quantification of atrial cardiomyopathy disease severity by electroanatomic voltage mapping and cardiac magnetic resonance imaging. Journal of Cardiovascular Electrophysiology. 2025;36(2):467-479. doi:10.1111/jce.16462

BibTeX
@article{Sim2025,
  author = {Sim, Iain and Lemus, Jose Alonso Solis and O'Shea, Christopher and Razeghi, Orod and Whitaker, John and Mukherjee, Rahul and O'Hare, Daniel and Fitzpatrick, Noel and Harrison, James and Gharaviri, Ali and O'Neill, Louisa and Kotadia, Irum and Roney, Caroline H and Grubb, Neil and Newby, David E and Dweck, Marc R and Masci, Pier-Giorgio and Wright, Matthew and Chiribiri, Amedeo and Niederer, Steven and O'Neill, Mark and Williams, Steven E},
  title = {Quantification of atrial cardiomyopathy disease severity by electroanatomic voltage mapping and cardiac magnetic resonance imaging},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2025},
  volume = {36},
  number = {2},
  pages = {467--479},
  doi = {10.1111/jce.16462}
}
Kostenlos starten →